Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Jizong Jia"'
Autor:
Wei Wang, Dequan Pan, Wenkun Fu, Xiangzhong Ye, Jinle Han, Lianwei Yang, Jizong Jia, Jian Liu, Rui Zhu, Yali Zhang, Che Liu, Jianghui Ye, Anca Selariu, Yuqiong Que, Qinjian Zhao, Ting Wu, Yimin Li, Jun Zhang, Tong Cheng, Hua Zhu, Ningshao Xia
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-15 (2022)
Current varicella vaccines retain neurovirulence and can establish latency and reactivate. Here, the authors present preclinical results of a rationally-designed, skin- and neuro-attenuated varicella vaccine candidate, v7D, showing its attenuation in
Externí odkaz:
https://doaj.org/article/9066b971d3e843a9a0bd9d71281bfdf9
Autor:
Jun Zhang, Min Zhao, Ningshao Xia, Yong Luo, Fei Ju, Chaolong Lin, Xian Jia, Zilong Xu, Rui Tian, Yanhua Lin, Yating Chang, Xiaoxuan Huang, Shaopeng Li, Wenfeng Ren, Yaning Qin, Mengqin Yu, Jizong Jia, Jinle Han, Wenxin Luo, Guo Fu, Xiangzhong Ye, Chenghao Huang
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 6 (2022)
Background Oncolytic viruses (OVs) are capable to inflame the tumor microenvironment (TME) and elicit infiltrating tumor-specific T cell responses. However, OV treatment negatively alters the cancer-immune set point in tumors to attenuate the antitum
Externí odkaz:
https://doaj.org/article/8080b2d9f46e4f4ea8e3525ab3073b5e
Autor:
Ningshao Xia, Fengcai Zhu, Shou-Jie Huang, Xiaohui Liu, Qi Chen, Chunlan Zhuang, Jinle Han, Anjuli Jaen, Thai Hung Do, Jonathan Peter, Alexander Dorado, Louie Tirador, Gelza Zabat, Ralph Villalobos, Gemalyn Gueco, Lauren Botha, Shirley Pertuz, Jiaxiang Tan, Kongxin Zhu, Jiali Quan, Hongyan Lin, Yue Huang, Jizong Jia, Xiafei Chu, Junyu Chen, Yixin Chen, Tianying Zhang, Ying-Ying Su, Changgui Li, Xiangzhong Ye, Ting Wu, Jun Zhang
The live-attenuated influenza virus vector-based intranasal vaccine (dNS1-RBD, Pneucolin®) is the world’s first COVID-19 mucosal vaccine to enter human trials, and has been issued for emergency use authorization in China. Here, we report safety an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::372819dd5e0f712e8b0acab3751924bd
https://doi.org/10.21203/rs.3.rs-2407050/v1
https://doi.org/10.21203/rs.3.rs-2407050/v1
Autor:
Shanshan Huang, Yaling Long, Yuan Gao, Wanling Lin, Lei Wang, Jizong Jiang, Xun Yuan, Yuan Chen, Peng Zhang, Qian Chu
Publikováno v:
Experimental Hematology & Oncology, Vol 13, Iss 1, Pp 1-14 (2024)
Abstract Background Aberrant activation of mesenchymal epithelial transition (MET) has been considered to mediate primary and acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in EGFR-mutant non-small ce
Externí odkaz:
https://doaj.org/article/072706ab2ba84703ae0b7712ea79cc75
Autor:
Junyu Chen, Pui Wang, Lunzhi Yuan, Liang Zhang, Limin Zhang, Hui Zhao, Congjie Chen, Xijing Wang, Jinle Han, Yaode Chen, Jizong Jia, Zhen Lu, Junping Hong, Zicen Lu, Qian Wang, Rirong Chen, Ruoyao Qi, Jian Ma, Min Zhou, Huan Yu, Chunlan Zhuang, Xiaohui Liu, Qiangyuan Han, Guosong Wang, Yingying Su, Quan Yuan, Tong Cheng, Ting Wu, Xiangzhong Ye, Tianying Zhang, Changgui Li, Jun Zhang, Huachen Zhu, Yixin Chen, Honglin Chen, Ningshao Xia
Publikováno v:
Science bulletin. 67(13)
Remarkable progress has been made in developing intramuscular vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); however, they are limited with respect to eliciting local immunity in the respiratory tract, which is the pri
Autor:
Lunzhi Yuan, Xijing Wang, Jizong Jia, Xiangzhong Ye, Rirong Chen, Pei Wang, Zhen Lu, Liqiang Chen, Changfa Fan, Junping Hong, Xiao-Hui Liu, Quan Yuan, Tianying Zhang, Zhang Limin, Hongling Chen, Congjie Chen, Ting Wu, Zicen Lu, Chualan Zhuang, Qiangyuan Han, Qian Wang, Mingping Cai, Yaode Chen, Jinle Han, Huan Yu, Tong Cheng, Ruoyao Qi, Ningshao Xia, Jian Ma, Yingying Su, Changgui Li, Liang Zhang, Wang Guosong, Jun Zhang, Hongbo Zhu, Yixin Chen, Min Zhou, Hui Zhao, Junyu Chen
Remarkable progress has been made in developing intramuscular vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); however, they are limited with respect to eliciting local immunity in the respiratory tract, which is the pri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8990a5623a0999011a10d394eeaffb1b
https://doi.org/10.1101/2021.11.13.468472
https://doi.org/10.1101/2021.11.13.468472
Autor:
Fei Ju, Yong Luo, Chaolong Lin, Xian Jia, Zilong Xu, Rui Tian, Yanhua Lin, Min Zhao, Yating Chang, Xiaoxuan Huang, Shaopeng Li, Wenfeng Ren, Yaning Qin, Mengqin Yu, Jizong Jia, Jinle Han, Wenxin Luo, Jun Zhang, Guo Fu, Xiangzhong Ye, Chenghao Huang, Ningshao Xia
Publikováno v:
Journal for ImmunoTherapy of Cancer. 10:e004762
BackgroundOncolytic viruses (OVs) are capable to inflame the tumor microenvironment (TME) and elicit infiltrating tumor-specific T cell responses. However, OV treatment negatively alters the cancer-immune set point in tumors to attenuate the antitumo
Publikováno v:
Frontiers in Molecular Biosciences, Vol 10 (2023)
ROS1 rearrangement is found in 0.9%–2.6% of people with non-small-cell lung cancers (NSCLCs). Tyrosine kinase inhibitors (TKIs) target ROS1 and can block tumor growth and provide clinical benefits to patients. This review summarizes the current kno
Externí odkaz:
https://doaj.org/article/3561805b3db14957994c0142f3ce18fa
Publikováno v:
Ecological Indicators, Vol 155, Iss , Pp 110905- (2023)
A crucial challenge in ecosystem management is the identification of trade-off effects among multiple ecosystem services (ESs), particularly in complex and ecologically vulnerable mountainous protected areas. Nevertheless, investigations into the spa
Externí odkaz:
https://doaj.org/article/74807908f81341e59268882058df5eee
Autor:
Jinle Han, Huan Zhao, Shuxuan Li, Ningshao Xia, Yajing Liu, Tong Cheng, Yixin Chen, Jizong Jia, Xiangzhong Ye, Lisheng Yang, Yimin Li, Longfa Xu
Publikováno v:
Applied Microbiology and Biotechnology. 100:2809-2815
Coxsackievirus A16 (CA16) is one of the major causative agents of hand, foot, and mouth disease (HFMD). No CA16 vaccine candidates have progressed to clinical trials so far. Immunogenicity studies indicated that different CA16 particles have much inf